Angewandte
Communications
Chemie
Protein Modifications
Isoxazole-Derived Amino Acids are Bromodomain-Binding Acetyl-
Lysine Mimics: Incorporation into Histone H4 Peptides and Histone
H3
Angelina R. Sekirnik (nꢀe Measures)+, David S. Hewings+, Natalie H. Theodoulou,
Lukass Jursins, Katie R. Lewendon, Laura E. Jennings, Timothy P. C. Rooney,
Abstract: A range of isoxazole-containing amino acids was
synthesized that displaced acetyl-lysine-containing peptides
from the BAZ2A, BRD4(1), and BRD9 bromodomains. Three
of these amino acids were incorporated into a histone H4-
mimicking peptide and their affinity for BRD4(1) was
assessed. Affinities of the isoxazole-containing peptides are
comparable to those of a hyperacetylated histone H4-mimick-
ing cognate peptide, and demonstrated a dependence on the
position at which the unnatural residue was incorporated. An
isoxazole-based alkylating agent was developed to selectively
alkylate cysteine residues in situ. Selective monoalkylation of
a histone H4-mimicking peptide, containing a lysine to cysteine
residue substitution (K12C), resulted in acetyl-lysine mimic
incorporation, with high affinity for the BRD4 bromodomain.
The same technology was used to alkylate a K18C mutant of
histone H3.
ized.[9] Neutralization of lysineꢀs positive charge by acetyla-
tion weakens the interaction of histone with DNA, thus
resulting in the relaxed, transcriptionally active form of
DNA—euchromatin. In addition, transcriptional machinery
is recruited to chromatin through the interaction of KAc with
reader protein modules: bromodomains.[10–12] The study of
lysine acetylation is therefore of high interest and the
generation of homogeneously modified proteins and peptides
is essential to achieve this. To this end, elegant chemical
strategies have been developed to synthesize single homoge-
neous forms of proteins, containing either KAc or an
analogue which functions similarly.[13–18] The value of these
modifications in uncovering the mechanistic roles of histone
modifications has been demonstrated,[19,20] particularly in the
study of sirtuins (see Figure S1 in the Supporting Informa-
tion).[21–27] However, only two of these KAc mimics have been
employed in the study of bromodomains: N-methanesulfonyl-
lysine (6; see Figure 2) has been reported as a stable KAc
mimic which binds to bromodomains when incorporated into
a p53-mimicking peptide;[28] KAc mimics containing methyl-
thiocarbonylthialysine (MTCTK; 7; Figure 2) interact two- to
fourfold less efficiently with the bromodomain of BRDT
compared to KAc.[18]
During the development of ligands for the bromodomain
and extra-terminal domain (BET) family of bromodomain-
containing proteins (BCPs), we identified the 3,5-dimethyl-
isoxazole (DMI) moiety as an effective KAc mimic.[29–31]
Sharp et al. subsequently showed that the DMI moiety is
most potent based on a comparison of KAc mimics.[32] Our
chembl/) revealed that 4-phenyl-3,5-dimethylisoxazole (1;
Figure 1A) possesses the highest binding efficiency index and
surface efficiency index[33] for the BET BCPs, BRD2 and
BRD4. We therefore decided to investigate whether the DMI
motif is a general KAc mimic which can be incorporated into
unnatural amino acids, and whether peptides in which KAc
has been substituted for these amino acids would retain
affinity for bromodomains. If successful, these amino acids
would be of high utility in generating homogenous peptides
and proteins in which the DMI functions as a stable replace-
ment for a KAc mark.
L
ysine acetylation is a prevalent post-translational modifi-
cation (PTM) which plays a fundamental role in regulating
protein function.[1,2] Although acetylated lysine (KAc) resi-
dues are found throughout the cellular environment,[3–5] it is
the role of this PTM in chromatin function which has
garnered most recent interest.[6] KAc is viewed as one of
the “marks” that comprises the epigenetic code,[7,8] and
enzymes that write (histone acetyl transferases) and erase
(histone deacetylases) this modification are well character-
[*] Dr. A. R. Sekirnik (nꢀe Measures),[+] Dr. D. S. Hewings,[+]
Dr. N. H. Theodoulou, L. Jursins, K. R. Lewendon, Dr. L. E. Jennings,
Dr. T. P. C. Rooney, Prof. Dr. S. J. Conway
Department of Chemistry, Chemistry Research Laboratory, University
of Oxford, Mansfield Road, Oxford, OX1 3TA (UK)
E-mail: stuart.conway@chem.ox.ac.uk
Dr. T. D. Heightman
Nuffield Department of Clinical Medicine, Structural Genomics
Consortium, University of Oxford, Old Road Campus Research
Building, Roosevelt Drive, Oxford, OX3 7DQ (UK)
[+] These authors contributed equally to this work.
Supporting information and the ORCID identification number(s) for
Analysis of the X-ray crystal structure of OXFBD02 (2;
Figure 1A)[31] bound to BRD4(1) (PDB code: 4J0S, carbon:
yellow) and the X-ray crystal structure of the histone H4-
mimicking peptide H41-12KAc5KAc8 (PDB code: 3UVW,
carbon: purple) in complex with BRD4(1) (Figure 1B)
ꢁ 2016 The Authors. Published by Wiley-VCH Verlag GmbH & Co.
KGaA. This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly
cited.
Angew. Chem. Int. Ed. 2016, 55, 1 – 6
ꢀ 2016 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1
These are not the final page numbers!